|
| 36799629 | MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors. | Clin Cancer Res | 2023 |
| 38000020 | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Sci Adv | 2023 |
| 37616542 | Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor. | Mol Cancer Ther | 2023 |
| 37549914 | Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2023 |
| 37841697 | Plexiform neurofibroma of the liver, with malignant transformation to MPNST, in a pediatric patient without neurofibromatosis type 1. | Neurooncol Adv | 2023 |
| 37246765 | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Neuro Oncol | 2023 |
| 37410426 | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Clin Cancer Res | 2023 |
| 37372318 | Complex/cryptic <i>EWSR1::FLI1/ERG</i> Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas. | Genes (Basel) | 2023 |
| 36821126 | Diffuse Pulmonary Metastases at Presentation of Giant Cell Tumor of Bone: A Case Report and Synthesis of Literature. | JBJS Case Connect | 2023 |
| 36854806 | Integrated molecular and clinical analysis of BRAF-mutant glioma in adults. | NPJ Precis Oncol | 2023 |
| 36476600 | Unresectable Metastatic Testicular Germ Cell Tumor With Low-grade Neuroglial Neoplasm, Stable After Radiation and Chemotherapy. | Appl Immunohistochem Mol Morphol | 2023 |
| 36778419 | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors. | bioRxiv | 2023 |
| 34841430 | Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling. | Dis Model Mech | 2022 |
| 35740680 | Therapeutic Vulnerability to ATR Inhibition in Concurrent <i>NF1</i> and <i>ATRX</i>-Deficient/ALT-Positive High-Grade Solid Tumors. | Cancers (Basel) | 2022 |
| 35466567 | Trends of lymph node sampling and metastasis in pediatric and young adult patients with clear cell, epithelioid, and synovial sarcomas. | Pediatr Blood Cancer | 2022 |
| 35534540 | Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. | Oncogene | 2022 |
| 35395680 | Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG). | Neuro Oncol | 2022 |
| 35459782 | Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. | Oncogene | 2022 |
| 36322658 | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Sci Adv | 2022 |
| 35184066 | Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma. | Am J Surg Pathol | 2022 |
| 35244537 | Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma. | Elife | 2022 |
| 34966100 | Considerations in Methods and Timing for Delivery of Genetic Counseling Information to Pediatric Oncology Patients and Families. | J Pediatr Hematol Oncol | 2022 |
| 33203698 | Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath Tumors. | Cancer Res | 2021 |
| 33591953 | Chromosome 8 gain is associated with high-grade transformation in MPNST. | JCI Insight | 2021 |
| 34433654 | Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAF[V600E]-Mutant Human Glioma. | Clin Cancer Res | 2021 |
| 34021032 | Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes. | J Immunother Cancer | 2021 |
| 34210658 | Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed <i>ALK</i> F1174L-mutated neuroblastoma. | Cold Spring Harb Mol Case Stud | 2021 |
| 33953640 | Predictors of Recurrence and Patterns of Initial Failure in Localized Ewing Sarcoma: A Contemporary 20-Year Experience. | Sarcoma | 2021 |
| 33229458 | Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor. | Clin Cancer Res | 2021 |
| 33370000 | Improving Detection of Cancer Predisposition Syndromes in Pediatric Oncology. | J Pediatr Hematol Oncol | 2021 |
| 31408245 | A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor. | Genes Chromosomes Cancer | 2020 |
| 32098059 | Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1. | Genes (Basel) | 2020 |
| 33032988 | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors. | Cancer Res | 2020 |
| 33028642 | <i>DICER1</i>-associated metastatic abdominopelvic primitive neuroectodermal tumor with an <i>EWSR1</i> rearrangement in a 16-yr-old female. | Cold Spring Harb Mol Case Stud | 2020 |
| 33235998 | Combination MEK and mTOR inhibitor therapy is active in models of glioblastoma. | Neurooncol Adv | 2020 |
| 32939963 | Socioeconomic and health care coverage disparities in children, adolescents, and young adults with sarcoma. | Pediatr Blood Cancer | 2020 |
| 32599735 | From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor. | Genes (Basel) | 2020 |
| 32882803 | Special Issue: "Genomics and Models of Nerve Sheath Tumors". | Genes (Basel) | 2020 |
| 32238401 | BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition. | Cold Spring Harb Mol Case Stud | 2020 |
| 32561749 | A clinically and genomically annotated nerve sheath tumor biospecimen repository. | Sci Data | 2020 |
| 32395555 | FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways. | Ann Transl Med | 2020 |
| 31158244 | Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition. | PLoS One | 2019 |
| 31466300 | BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors. | Cancers (Basel) | 2019 |
| 31462295 | Telomere alterations in neurofibromatosis type 1-associated solid tumors. | Acta Neuropathol Commun | 2019 |
| 31192863 | Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status. | Am J Surg Pathol | 2019 |
| 31506385 | A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid Tumors. | Clin Cancer Res | 2019 |
| 30842593 | Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. | Nat Cell Biol | 2019 |
| 28859862 | The promise of signal transduction in genetically driven sarcomas of the nerve. | Exp Neurol | 2018 |
| 29975249 | Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum. | Am J Surg Pathol | 2018 |
| 29880583 | A Secondary Mutation in <i>BRAF</i> Confers Resistance to RAF Inhibition in a <i>BRAF</i><sup>V600E</sup>-Mutant Brain Tumor. | Cancer Discov | 2018 |